Drug Shortage Report for PAMIDRONATE DISODIUM OMEGA 3 MG/ML

Last updated on 2017-10-05 History
Report ID 2163
Drug Identification Number 02249669
Brand name PAMIDRONATE DISODIUM OMEGA 3 MG/ML
Common or Proper name Pamidrontae Disodium for Injection 30mg/10mL
Company Name OMEGA LABORATORIES LIMITED
Market Status DORMANT
Active Ingredient(s) PAMIDRONATE DISODIUM
Strength(s) 3.0MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10mL vial
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2013-01-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments 6mg/mL and 9mg/mL formats remain available.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-03-14 French Compare
v6 2017-03-14 English Compare
v5 2017-03-14 French Compare
v4 2017-03-14 English Compare
v3 2017-03-14 French Compare
v2 2017-03-14 English Compare
v1 2017-03-14 English Compare

Showing 1 to 7 of 7